Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Tapinarof Cream, 1% in Subjects With Atopic Dermatitis

NCT05142774 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT05142774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Tapinarof Cream, 1% in Subjects With Atopic Dermatitis
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
October 28, 2021
Completion date
March 7, 2024
Enrollment
728 (actual)
Sites
112

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis